Wang et al. showed that in esophageal cancer, low doses of metformin reprogrammed the tumor immune microenvironment (TIME) in an anti-cancer direction by increasing the proportion of CD8+ cells (Wang et al., 2020). This evidence concerns the gene CD8A and esophageal cancer.